Lifecore Biomedical, Inc. (FRA:LDE)

Market Cap	274.04M +19.6%
Revenue (ttm)	113.70M +0.5%
Net Income	-39.14M
EPS	-1.12
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	7.10
Previous Close	7.30
Day's Range	7.10 - 7.10
52-Week Range	4.56 - 7.45
Beta	n/a
RSI	53.88
Earnings Date	Jan 2, 2026

About Lifecore Biomedical

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacture of hyaluronate acid in bulk form; and formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. It also provides product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot stud...

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Employees: 406
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LDE

Financial Performance

Financial numbers in USD